Cargando…
Cross-Validation of the Foundation Pain Index with PROMIS-29 in Chronic Pain Patients
PURPOSE: Discovery and validation of pragmatic biomarkers represent significant advancements in the field of pain management. Evaluating relationships between objective biomarkers and patient-reported outcomes (PROs) is an effective way to gain mechanistic insight into the potential role of biochemi...
Autores principales: | Pope, Jason E, Fishman, Michael A, Gunn, Joshua A, Cotten, Bradley M, Hill, Melissa M, Deer, Timothy R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412832/ https://www.ncbi.nlm.nih.gov/pubmed/34512007 http://dx.doi.org/10.2147/JPR.S314021 |
Ejemplares similares
-
A Retrospective, Multicenter, Quantitative Analysis of Patients’ Baseline Pain Quality (PROMIS-29) Entering into Pain and Spine Practices in the United States (ALIGN)
por: Pope, Jason E., et al.
Publicado: (2021) -
Clinical Validation of a Multi-Biomarker Assay for the Evaluation of Chronic Pain Patients in a Cross-Sectional, Observational Study
por: Amirdelfan, Kasra, et al.
Publicado: (2020) -
Validation of PROMIS Profile‐29 in adults with hemophilia in the Netherlands
por: van Balen, Erna C., et al.
Publicado: (2021) -
The Impact of Clinical Setting on Evaluating Patients Using the PROMIS-29 Baseline Measures in the COVID Era: A Retrospective Multicenter Quantitative Analysis
por: Engle, Alyson M., et al.
Publicado: (2021) -
The Norwegian PROMIS-29: psychometric validation in the general population for Norway
por: Garratt, Andrew M., et al.
Publicado: (2021)